🇺🇸 FDA
Patent

US 9889137

Therapeutically active compounds and their methods of use

granted A61KA61K31/185A61K31/53

Quick answer

US patent 9889137 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/185, A61K31/53, A61K9/0053, A61P